Renin-angiotensin system and progression of chronic liver diseases

Journal of Gastroenterology

Volumn 41, Issue 10, 2006, Pages 1020-1022

  Yoshiji, Hitoshi ^a   Fukui, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FARNOQUINONE; IMATINIB; INTERFERON; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL TRIAL; DISEASE COURSE; DOSE RESPONSE; DRUG SAFETY; DRUG SELECTIVITY; EDITORIAL; GENE EXPRESSION; GROWTH INHIBITION; HEPATITIS C; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; LONG TERM CARE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; REINFECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

CHRONIC DISEASE; DISEASE PROGRESSION; HUMANS; LIVER DISEASES; RENIN-ANGIOTENSIN SYSTEM;

EID: 33750995848     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-006-1897-8     Document Type: Editorial

References (35)

1. A Helmy R Jalan DE Newby PC Hayes DJ Webb 2000 Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis Gastroenterology 118 565-72 10702208 10.1016/S0016-5085(00)70263-0
2. JC Garcia-Pagan J Bosch J Rodes 1995 The role of vasoactive mediators in portal hypertension Semin Gastrointest Dis 6 140-7 7551971
3. R Bataller P Gines JM Nicolas MN Gorbig E Garcia-Ramallo X Gasull 2000 Angiotensin II induces contraction and proliferation of human hepatic stellate cells Gastroenterology 118 1149-56 10833490 10.1016/ S0016-5085(00)70368-4
4. R Bataller P Sancho-Bru P Gines JM Lora A Al-Garawi M Sole 2003 Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II Gastroenterology 125 117-25 12851877 10.1016/S0016-5085(03)00695-4
5. R Bataller P Sancho-Bru Gines DA Brenner 2005 Liver fibrogenesis: A new role for the renin-angiotensin system Antioxid Redox Signal 7 1346-55 16115040 10.1089/ars.2005.7.1346
6. H Yoshiji S Kuriyama J Yoshii Y Ikenaka R Noguchi K Yanase 2003 Angiotensin-II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fibrosis development Hepatol Res 27 51-6 12957207 10.1016/S1386-6346(03)00160-8
7. Y Ikura M Ohsawa N Shirai Y Sugama H Fukushima T Suekane 2005 Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension Hepatol Res 32 107-16 15905119 10.1016/j.hepres.2005.01.017
8. JB Dixon PS Bhathal JR Jonsson AF Dixon EE Powell PE O'Brien 2003 Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese J Hepatol 39 967-71 14642613 10.1016/S0168-8278(03)00459-8
9. EE Powell CJ Edwards-Smith JL Hay AD Clouston DH Crawford C Shorthouse 2000 Host genetic factors influence disease progression in chronic hepatitis C Hepatology 31 828-33 10733535 10.1053/he.2000.6253
10. M Ueki M Koda S Yamamoto Y Matsunaga Y Murawaki 2006 Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats J Gastroenterol 41 996-1004
11. JR Jonsson AD Clouston Y Ando LI Kelemen MJ Horn MD Adamson 2001 Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis Gastroenterology 121 148-55 11438504 10.1053/ gast.2001.25480
12. T Ohishi H Saito K Tsusaka K Toda H Inagaki Y Hamada 2001 Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats Hepatol Res 21 147-58 11551835 10.1016/S1386-6346(01)00102-4
13. H Yoshiji S Kuriyama J Yoshii Y Ikenaka R Noguchi T Nakatani 2001 Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats Hepatology 34 745-50 11584371
14. H Yoshiji J Yoshii Y Ikenaka R Noguchi H Tsujinoue T Nakatani 2002 Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats J Hepatol 37 22-30 12076858 10.1016/S0168-8278(02)00104-6
15. K Kanno S Tazuma K Chayama 2003 AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4) Biochem Biophys Res Commun 308 177-83 12890498 10.1016/S0006-291X(03)01357-3
16. L Yang R Bataller J Dulyx TM Coffman P Gines RA Rippe 2005 Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice J Hepatol 43 317-23 15964094 10.1016/j.jhep.2005.02.034
17. Y Terui T Saito H Watanabe H Togashi S Kawata Y Kamada 2002 Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C Hepatology 36 102212297856 10.1053/jhep.2002.32679
18. S Yokohama M Yoneda M Haneda S Okamoto M Okada K Aso 2004 Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis Hepatology 40 1222-5 15382153 10.1002/ hep.20420
19. A Rimola MC Londono G Guevara M Bruguera M Navasa X Forns 2004 Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation Transplantation 78 686-91 15371669 10.1097/01.TP.0000128913.09774.CE
20. H Yoshiji S Kuriyama R Noguchi J Yoshii Y Ikenaka K Yanase 2005 Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development Liver Int 25 153-61 15698413 10.1111/j.1478-3231.2005.01038.x
21. H Yoshiji R Noguchi S Kuriyama Y Ikenaka J Yoshii K Yanase 2005 Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats Am J Physiol Gastrointest Liver Physiol 288 G907-13 15618280 10.1152/ ajpgi.00420.2004
22. P Carmeliet 2005 Angiogenesis in life, disease and medicine Nature 438 932-6 16355210 10.1038/nature04478
23. H Yoshiji S Kuriyama H Fukui 2002 Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor Tumour Biol 23 348-56 12677092 10.1159/000069792
24. Yoshiji H, Kuriyama S, Noguchi R, Ikenaka Y, Kitade M, Kaji K, et al. Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development. Hepatol Res 2006 in press
25. H Yoshiji S Kuriyama J Yoshii Y Ikenaka R Noguchi DJ Hicklin 2003 Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis Gut 52 1347-54 12912869 10.1136/gut.52.9.1347
26. K Suzuki N Hayashi Y Miyamoto M Yamamoto K Ohkawa Y Ito 1996 Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma Cancer Res 56 3004-9 8674055
27. R Yamaguchi H Yano A Iemura S Ogasawara M Haramaki M Kojiro 1998 Expression of vascular endothelial growth factor in human hepatocellular carcinoma Hepatology 28 68-77 9657098 10.1002/hep.510280111
28. K Hori S Saito H Takahashi H Sato H Maeda Y Sato 2000 Tumor-selective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochloride Jpn J Cancer Res 91 261-9 10761715
29. H Yoshiji S Kuriyama R Noguchi H Fukui 2004 Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapy Curr Cancer Drug Targets 4 555-67 15578913 10.2174/1568009043332790
30. R Noguchi H Yoshiji S Kuriyama J Yoshii Y Ikenaka K Yanase 2003 Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis Clin Cancer Res 9 6038-45 14676130
31. H Yoshiji S Kuriyama R Noguchi J Yoshii Y Ikenaka K Yanase 2005 Combination of vitamin K(2) and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression J Hepatol 42 687-93 15826718 10.1016/j.jhep.2004.12.025
32. S Frachon G Gouysse J Dumorti A Couvelard M Nejjari F Mion 2001 Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study J Hepatol 34 850-7 11451168 10.1016/ S0168-8278(01)00049-6
33. R Mazzanti L Messerini L Monsacchi G Buzzelli AL Zignego M Foschi 1997 Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis Hepatology 25 229-34 8985296 10.1002/hep.510250142
34. H Yoshiji S Kuriyama J Yoshii Y Ikenaka R Noguchi DJ Hicklin 2004 Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice Hepatology 39 1517-24 15185292 10.1002/hep.20218
35. H Yoshiji R Noguchi S Kuriyama J Yoshii Y Ikenaka K Yanase 2005 Suppression of renin-angiotensin system attenuates hepatocarcinogenesis via angiogenesis inhibition in rats Anticancer Res 25 3335-40 16101147